Emerging Market Crackdowns Raise Doubts About Multinational Sales Strategies
This article was originally published in PharmAsia News
Executive Summary
Restrictive new drug policies in China and India, similar action pending in Brazil and strict price caps imposed by Turkey could be a signal to Western drug makers they should not take the emerging markets for granted.